Consolidated Portfolio Review Corp’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $441K | Buy |
2,373
+237
| +11% | +$44K | 0.06% | 275 |
|
|
2025
Q1 | $448K | Buy |
2,136
+150
| +8% | +$31.4K | 0.07% | 240 |
|
|
2024
Q4 | $353K | Buy |
1,986
+389
| +24% | +$69.1K | 0.06% | 271 |
|
|
2024
Q3 | $315K | Sell |
1,597
-541
| -25% | -$107K | 0.07% | 240 |
|
|
2024
Q2 | $367K | Buy |
2,138
+283
| +15% | +$48.5K | 0.09% | 203 |
|
|
2024
Q1 | $338K | Sell |
1,855
-1,198
| -39% | -$218K | 0.09% | 197 |
|
|
2023
Q4 | $473K | Sell |
3,053
-194
| -6% | -$30.1K | 0.11% | 178 |
|
|
2023
Q3 | $484K | Buy |
3,247
+106
| +3% | +$15.8K | 0.12% | 172 |
|
|
2023
Q2 | $423K | Sell |
3,141
-1
| -0% | -$135 | 0.1% | 179 |
|
|
2023
Q1 | $501K | Buy |
+3,142
| New | +$501K | 0.14% | 159 |
|